B-lymphocyte subpopulations in patients with selective IgA deficiency
Language English Country Netherlands Media print-electronic
Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Common Variable Immunodeficiency immunology MeSH
- Cell Differentiation MeSH
- IgA Deficiency immunology MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- B-Lymphocyte Subsets cytology immunology MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
INTRODUCTION: Selective deficiency IgA (IgAD) is the most common primary abnormality of immunoglobulin production with unknown pathophysiology. It is genetically related to common variable immunodeficiency (CVID), where besides IgA also IgG and frequently IgM serum levels are decreased. In this study we focused on determination of B-lymphocyte developmental stages and searching for similarities between CVID and IgAD. MATERIALS AND METHODS: Using flow cytometry we determined major lymphocyte subpopulations and B-lymphocyte subsets: naïve (CD27(-)IgD(+)), marginal zone cells (CD27(+)IgD(+)), class-switched memory cells (CD27(+)IgD(-)), "double-negative" B cells (CD27(-)IgD(-)), transitional cells (IgM(++)CD38(++)), plasmablasts (CD38(+++)IgM(+) or IgM(-)), and CD21(low)CD38(low) cells in 80 patients with IgAD, 48 patients with CVID, and 80 control persons. RESULTS: Compared to healthy controls, a decrease in the absolute number and frequency of CD4+ cells (both < 0.001) was observed in IgAD patients. A decrease in the frequency of switched memory cells (P < 0.001), transitional cells (P = 0.035) as well as plasmablasts (P < 0.001) and an increase in the CD21(low)CD38(low) subset (P = 0.007) was observed in IgAD patients compared to control persons. No significant differences were observed in the remaining B-cell developmental subsets. A decrease in CD27(+)IgD(-) (<0.4% of peripheral blood lymphocytes), frequently observed in CVID patients and also previously reported in IgAD, was found in only five patients (6%) with IgAD, two of them being first-degree relatives of CVID patients. CONCLUSION: Our results show a decrease of terminally differentiated B-lymphocyte subsets in patients with IgAD, similar as previously found in patients with CVID, but these results are less expressed than in CVID patients.
See more in PubMed
Int Arch Allergy Immunol. 2011;156(4):462-8 PubMed
Clin Exp Immunol. 1970 Dec;7(6):833-8 PubMed
Eur J Immunol. 2000 Sep;30(9):2516-20 PubMed
Blood. 2008 Jan 1;111(1):77-85 PubMed
Blood. 1990 Nov 15;76(10):2046-51 PubMed
Clin Immunol. 2004 Nov;113(2):161-71 PubMed
Int Arch Allergy Immunol. 2010;153(1):95-101 PubMed
Clin Exp Immunol. 2007 Feb;147(2):249-54 PubMed
J Immunol. 2008 Aug 1;181(3):1767-79 PubMed
Blood. 2010 Jun 17;115(24):5026-36 PubMed
Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13451-6 PubMed
J Immunol. 1995 Apr 1;154(7):3156-61 PubMed
Blood. 2008 Sep 1;112(5):1570-80 PubMed
Int Arch Allergy Immunol. 2000 Oct;123(2):177-80 PubMed
Clin Immunol Immunopathol. 1995 Nov;77(2):185-92 PubMed
Vaccine. 2011 May 31;29(24):4142-50 PubMed
Clin Immunol Immunopathol. 1996 Sep;80(3 Pt 1):333-5 PubMed
Clin Exp Immunol. 2006 Feb;143(2):373-9 PubMed
Clin Immunol. 2006 Sep;120(3):310-8 PubMed
Clin Immunol. 1999 Dec;93(3):190-7 PubMed
Clin Immunol. 1999 Jul;92(1):34-48 PubMed
Cytometry B Clin Cytom. 2008 Sep;74(5):261-71 PubMed
Clin Immunol. 2006 Nov;121(2):203-14 PubMed
Clin Exp Immunol. 2005 Jun;140(3):532-9 PubMed
Iran J Allergy Asthma Immunol. 2004 Sep;3(3):103-13 PubMed
Clin Exp Immunol. 2006 Jun;144(3):458-66 PubMed
Clin Immunol. 2005 Jul;116(1):37-41 PubMed
Blood. 2002 Mar 1;99(5):1544-51 PubMed
Int Arch Allergy Immunol. 2008;147(2):87-92 PubMed
Br J Haematol. 2009 Jun;145(6):709-27 PubMed
Blood. 2009 Nov 5;114(19):4089-98 PubMed
Nat Rev Immunol. 2008 Jun;8(6):421-34 PubMed
Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies